World Allergy Association statement on climate change, allergy and asthma
The prevalence of allergic airway diseases such as asthma and rhinitis has increased dramatically to epidemic proportions worldwide. Besides air pollution from industry derived emissions and motor veh ...

Read more

Clean air is of supreme importance to our health and environment –European Parliament Group on Allergy and Asthma
On the 1st of July, the European Parliament Interest Group on Allergy and Asthma met to discuss how air quality affects EU citizens’ health and how allergy and asthma – which are among the top chronic ...

Read more

Patients vision to prevent allergy at EAACI Congress
If healthcare professionals, patients, industry leaders and policy makers join forces to reduce the burden of allergy, allergy prevention can be achieved in the future. That is the vision we presented ...

Read more

Could genetically modified plants be beneficial for people with allergies?
On the 17th of June, the European Food Safety Authority (EFSA) organised a workshop on the allergenicity assessment of genetically modified plants, gathering over 80 international experts. Following t ...

Read more

PRESS RELEASE: International Ragweed Day 2015
[French version below] More Europeans will be allergic to pollen if no measure is taken to reduce exposure Brussels, 24 June 2015, ahead of INTERNATIONAL RAGWEED DAY – Climate change is a result o ...

Read more

ATOPICA Results: The air concentrations of allergenic ragweed pollen could quadruple in Europe by 2050
Early this year, EU-funded Project Atopica presented its final results: were published! The main aim of the project was to further understand how global and regional climate, land use and air quality  ...

Read more

Four more MEPs support the EP Interest Group on Allergy and Asthma
On the 6th May, one day after the World Asthma Day, EFA President Breda Flood and the leadership of the European Academy of Allergy and Clinical Immunology (EAACI) met with several Members of the Euro ...

Read more

Novel vaccine could open new horizons against house dust mites allergy
Many asthma patients have dust mite allergy, but maybe not for so long: researchers from France and Austria have developed a new preventive vaccine. House dust mites are microscopic organisms that t ...

Read more

Save the Date: MeDALL Results Symposium
We are pleased to announce on behalf of the MeDALL Consortium the celebration of the event “Are Europeans developing more allergies? – From research to policies”, an event at the European Parliam ...

Read more

EFA Members news (April 2015)
This month patients associations have mobilized at national level through a wide variety of activities to raise awareness about allergy (UK), indoor air quality in schools (Sweden), asthma (Finland),  ...

Read more

EU Policy update (April 2015)
Launch of Interest Group on Allergy and Asthma: EFA/EAACI REPORT The European Parliament Interest Group on Allergy and Asthma was launched on the 25th of March. The event was co-hosted by the Inte ...

Read more

MeDALL - EU funded project
Allergy often starts in childhood. MeDALL (Mechanisms of the Development of ALLergy)aims at improving the health of European citizens by investigating the mechanisms causing allergy. The project speci ...

Read more

New EP Group on Asthma and Allergy
MEPs Sirpa Pietikainen and Nessa Childers, patients and doctors have joined forces in an Interest Group to take actions on allergy and asthma in Europe, launched on 25 March at the European Parliament ...

Read more

Pollen is in the air (March 2015)
The spring season is back and with it the increase of allergy troubles. Allergies affect more than 20% of the EU population. Today, 150 million Europeans are living with allergies, the most preva ...

Read more

Press Release: EP Interest Group on Allergy and Asthma
Launch of new European Parliament Interest Group on Allergy and Asthma Brussels, 25 March, 2015 – Members of the European Parliament (MEPs), patients, doctors have joined forces in an Interest Group ...

Read more

Allergy explained
Hello, If you are reading this article because you or someone close to you live with allergies, do not worry, you are not alone. At EFA, we represent the 150 million of Europeans living with allergi ...

Read more

Relieve the burden of allergies - EFA project
Allergology is not recognised as a medical specialisation in most European countries and respiratory allergies are often treated at primary care services. However, primary care physicians usually have ...

Read more

Clinical trials for asthma, allergy and COPD
Clinical trials are research conducted in humans to prove the effects of one or more investigational medicinal products. All investigational medicinal products should go through clinical trial. All me ...

Read more

Medical devices for allergy and respiratory diseases
Medical devices can increase life expectancy and quality of life. They are also fundamental for chronic disease patients as they help them manage their symptoms, contributing to patient-centred and di ...

Read more

EFA Projects update (January 2015)
Our contribution on allergy action at national level was presented to the Italian Ministry of Health by a delegation formed by patients, doctors, and researchers and our work to enable air travel with ...

Read more